Google TrendPANTHERS VS BLUE JACKETS (200+) — Gameday 7: Florida Panthers at Columbus Blue Jackets
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Real-world antipsychotic" (30 stories)

Top Headline Story

Real-world antipsychotic prescribing pathways and treatment modifications in schizophrenia spectrum disorders: evidence from the United Arab Emirates
Lead StoryFrontiersworld
Apr 24

Real-world antipsychotic prescribing pathways and treatment modifications in schizophrenia spectrum disorders: evidence from the United Arab Emirates

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQc292UHh6amptTTFwWEVxLU5LNDgzdTRPRlhWeVJLaTNpUk9xeEY4VjVtTVpXRHpDZU9KNXl2aC01TVdUYVFwWTBrXzhObTlHdHNqYnEwY1VNVU5XdkZIOW9Fd1FiV0szc2lyN1hHZHZOcVR4WE9sUnNPVW4tS2lOZy1IQmpWMlVGcmhweHBiZTd4UHdM?oc=5" target="_blank">Real-world antipsychotic prescribing pathways and treatment modifications in schizophrenia spectrum disorders: evidence from the United Arab Emirates</a>  <font color="#6f6f6f">Frontiers</font>

Real-time search volume
200+19m ago

panthers vs blue jackets

Gameday 7: Florida Panthers at Columbus Blue Jackets

5000+29m ago

posiciones de atlético de madrid contra manchester united

Atlético 2 - 0 Manchester United: resumen, goles y resultado de la Champions League

2000+29m ago

devils vs red wings

Roster Changes for Devils vs. Red Wings | PREVIEW | New Jersey Devils

5000+29m ago

lioness season 3

Thank Zoe Saldaña for ‘Lioness’ Season 3’s Perfect Cliff-Hanger

Search Results for "Real-world antipsychotic"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Long-Term and Real-World Safety Data on Antipsychotic Agitation Therapy
Psychiatric Timesworld

Long-Term and Real-World Safety Data on Antipsychotic Agitation Therapy

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxQNGktZGxaM28zbUxVd3BtajBVcGhTWEVXWkUzbkVHZjRRRjJWd21zY3VxYUtFNWhvQmRYbkIzdXBkN2lLcGkxa0xzVy1kZDlwSlZaa3lsa2FzUFduVlhSbGgwZ2JGMHVzazNHWVgyd09PcTZmTDVkcjQ1LXBQczQycnphclhkWTVqZXdNYTBqWk1uYi1ZNHdrLUFOSHcxXzZkMzE5ZWU2R2FkaVBfd0E?oc=5" target="_blank">Long-Term and Real-World Safety Data on Antipsychotic Agitation Therapy</a>  <font color="#6f6f6f">Psychiatric Times</font>

Antipsychotic treatment patterns and cardiometabolic medicine use: current real-world evidence
Cambridge University Press & Assessmentworld

Antipsychotic treatment patterns and cardiometabolic medicine use: current real-world evidence

<a href="https://news.google.com/rss/articles/CBMitgJBVV95cUxPZTJkODVHVGZvRjBYbC01S0NOZ05mLTlPcXBTalBhNEhJR1Awdlp4QVhraURqTkh2WXF6UEFvU0tyWm94Z1dZeXFvOTcxdXZPSzZKWVRzOUoxTW02MnBwT0ZNOEc0V3E0eEZRRDdGOE5QMFFGQkU1RU5pNDVaQTNGN0pnYmpxTmh3N3dUU3lFYmRLTEc3TFlhVHpHeDZ2WnlBNkZBcHFMeWJxbV9ETFBqeDlKMzdackhaaUh6dzh3RldaWERMZHBxTGR6XzlvcTRuWHltMVV3VV9URms2TWVzbUpPY1c5V3Azd2VEd3d4T2VRRXdlTkpTVHFvOEpUZndsenJXZTJGV2YyYXYtRVBGc29tQU1xS1hTdU1DRmlndHA2aktVY0NtSjQyVE9ENkdOTE9oOXdn?oc=5" target="_blank">Antipsychotic treatment patterns and cardiometabolic medicine use: current real-world evidence</a>  <font color="#6f6f6f">Cambridge University Press & Assessment</font>

Outcomes and Practice Patterns of LAI Versus Oral Antipsychotics Among Patients With Bipolar I Disorder in the US
Psychiatrist.comtech

Outcomes and Practice Patterns of LAI Versus Oral Antipsychotics Among Patients With Bipolar I Disorder in the US

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQTDF4LUxMVGxtSmhRSDZPQk1iUHBGY3NPRHZDSkJSbmZJcmZ5SVRtTnFOeGx6bUZvQ0Q1Y3R2Ull5QnlLazJ0bHJwbXhNd01pWi1ZTEFTQnNPSmZ2SnBLSC0yQkRYa0Y1UlZsS0hHZGt3RVNVRlJIWGIydGNubjJXRmgycHJ4dlRNSm5kR3RpaGVDS0hiN2tvZFlWaDlaNjZaaEsyRXc0VEc3Qmw5b2VCbl93UTlSWHJ5ZzRV?oc=5" target="_blank">Outcomes and Practice Patterns of LAI Versus Oral Antipsychotics Among Patients With Bipolar I Disorder in the US</a>  <font color="#6f6f6f">Psychiatrist.com</font>

Real-World and Long-Term Trial Data Show Xanomeline/Trospium Cuts Hospitalizations, Antipsychotic Burden in Schizophrenia
Psychiatric Timesworld

Real-World and Long-Term Trial Data Show Xanomeline/Trospium Cuts Hospitalizations, Antipsychotic Burden in Schizophrenia

<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxObG9NbWUtb2ExbjltbF9VLVNsM0JZOWh3b3ZUQ25WTEstZVRlOEhKT2NHR2NBcG5iZGtxX3lScVhnWmFIZnI4Q2dMdVJ2bkN0YnBidE5ObmE4aFNoQkZXbmdFd3E3NG43b2ZONlVGVmRBT2RrR1YtVk5mcF9aOXlFLWdCdjNUX3hGdnlxMTE0SzhmVm5XVmQ5anc5VTBuT3JwakhuNEdJTjFMRFg1dEhfYS1mUThIMjN2MUxSMEZyYTVMVkQyM3hjcnB3Snc2YmRrZ0FNdWNLel82UWNIQWJKYllxTUJ5eWpHUHllZFVocw?oc=5" target="_blank">Real-World and Long-Term Trial Data Show Xanomeline/Trospium Cuts Hospitalizations, Antipsychotic Burden in Schizophrenia</a>  <font color="#6f6f6f">Psychiatric Times</font>

Predicting functional remission after antipsychotic discontinuation: a real-world study in schizophrenia
Cambridge University Press & Assessmentworld

Predicting functional remission after antipsychotic discontinuation: a real-world study in schizophrenia

<a href="https://news.google.com/rss/articles/CBMirwJBVV95cUxQaVZQd01KdGxXamRDSmNBSkxMaEQyQU1NUkZIVnRESktoUlhhQzY3VVVsbm1WbkplbUczaVZ2enRZQmpXbnBtVHVIbU5Odi1hdzlCVGdRSXVUNjI3UkhvOENUeDdnT28zSUg4T3ZKcVc5MVZIMTJWYVdxM2I1T3NsU21NQVZSajFSTExMMnZrTGxVS1FBZWZRME9hZmpUNUxuWjRHbnBOVmlNQkR5a2E2MGZzdmpqak8xM0FYMXRCTGpuZHM4dFkwZ1h3ZHNpQzFZbEV0eXVLUUhyNzNFZzRoNHdfeVIxTlhmWHpoYS14VGNTb1ZyVXJIXzRyZzRGZ1UyckRxRi1QVmZSc2w2MEVRNGhIWW9CSmpsSEc2OFdTUlRXSnV2QzZMRVRHTzV4WFU?oc=5" target="_blank">Predicting functional remission after antipsychotic discontinuation: a real-world study in schizophrenia</a>  <font color="#6f6f6f">Cambridge University Press & Assessment</font>

Risk of major adverse cardiovascular events with aripiprazole versus olanzapine, quetiapine, and risperidone in severe mental illness: a target trial emulation
Naturegeneral

Risk of major adverse cardiovascular events with aripiprazole versus olanzapine, quetiapine, and risperidone in severe mental illness: a target trial emulation

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9tU05WZV9hX3g0emtLcUZWZ0RKTmFOcTRTcmhUVUc5cFg3VzQxeXpHLS1wNi1kZWdkbmNDd21sY3AyRnpZZ3FnMkFXbEUwS2hCeVVIU01lZFgwQk95U0JR?oc=5" target="_blank">Risk of major adverse cardiovascular events with aripiprazole versus olanzapine, quetiapine, and risperidone in severe mental illness: a target trial emulation</a>  <font color="#6f6f6f">Nature</font>

Rare side effects of antipsychotic medications provide new evidence for safer global prescribing
Medical Xpressgeneral

Rare side effects of antipsychotic medications provide new evidence for safer global prescribing

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQbjNWd3pCVllHSWRsUldDdDBBLUMySmtPZHNHM0trRkJNZ01uNEUwRlF5cUFXcmQzVmNXWmhkTEZkVy1IamQxUzBVMVVOOUxSeEZtRHFnWUthUmwzZ252ZHk4VWhsY3RJU2hDYUJYYzlwNUpzTDZldFVpakRMQUJXSGFoTERJNnNyeFNBSEs2X2o?oc=5" target="_blank">Rare side effects of antipsychotic medications provide new evidence for safer global prescribing</a>  <font color="#6f6f6f">Medical Xpress</font>

Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study
The Lancetworld

Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdVZuMnJYWGpvNUhyLXl1Q0UxSnFTS0E4VWw5dHpUMnNiZFJ0UlRMdUhHTnV2TkZlcWxJZ0pGQ2I2Q1NxQUNkYS1jUjNuZXJEb3MwbnFuMUVObjBXcUV4c0Q1NElQSHN0Qjk0b2E3cXNFQmVwMFZScXEyMkZzVzQzMWtlWi04UTk0VnJj?oc=5" target="_blank">Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study</a>  <font color="#6f6f6f">The Lancet</font>

Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis
Psychiatry Onlinegeneral

Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis

<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE5QNmVMY0RUUkxJUEZNanNkWHhUMVNRdVZDQkRmZXhKQWE4cmg0MHNtRUJzWV8zOTBxN2lvZnExSk14THhVRFhpNlFQNlN0M1ZtalFzTzBral81dVJfckpUU04wakgyWVpnVGpSc3RrSTE?oc=5" target="_blank">Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis</a>  <font color="#6f6f6f">Psychiatry Online</font>

Efficacy of Antipsychotics for First-Episode Psychosis and Cannabis Use Disorder
Psychiatry Advisorgeneral

Efficacy of Antipsychotics for First-Episode Psychosis and Cannabis Use Disorder

<a href="https://news.google.com/rss/articles/CBMif0FVX3lxTE85Yy1iRXpTcVcxWVN3TzUtOTFYMkh1LXBJR3ZmSTFqcmlfbFNidUFiYUxyZWcydU1XSlpkQm45NzVWQmY5WjB0X1lmcnFmVlNGN2xtaXhLeE8zTDZ0M0UzUDF6RVlHelBvM1B5WWt2Q3JqeTVSSW1PakJRYWt1bFE?oc=5" target="_blank">Efficacy of Antipsychotics for First-Episode Psychosis and Cannabis Use Disorder</a>  <font color="#6f6f6f">Psychiatry Advisor</font>

HKUMed finds that long-acting injectable antipsychotics lower relapse in patients with bipolar disorder and older adults with schizophrenia
EurekAlert! Science News Releasesgeneral

HKUMed finds that long-acting injectable antipsychotics lower relapse in patients with bipolar disorder and older adults with schizophrenia

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE82U2xsMFZXSkkzZ1liVDFleXFET2VyWmJEVHBKWEMyVlBLUU1FMHlockIzQklWRkd4azRiSTJ3eHdTZWJIcnhabUIyRWJrSUtVTUQ3dlpTZXRrcG55?oc=5" target="_blank">HKUMed finds that long-acting injectable antipsychotics lower relapse in patients with bipolar disorder and older adults with schizophrenia</a>  <font color="#6f6f6f">EurekAlert! Science News Releases</font>

Real-World Transition Strategies for Initiating Xanomeline–Trospium in Schizophrenia
Psychiatrist.comworld

Real-World Transition Strategies for Initiating Xanomeline–Trospium in Schizophrenia

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNbDdfWE5YRFByaC1BeW5rVnlRQmZmcHJfcW5zX3ZXbVVfUlItaWc5SWZQMDlLQkJISmFkRjdwbzBQN25jajVxanJEY0lqMk84OGIzQjgxNUlGeWdZQk95d0xnWFFUZWMxbU1qc2drZnppcG9QZjhOU19hV3UtdXdBSkZiWnEtMXNFeVAwMDFtWElfTEFlRVhoWnJrbTlLTWNjakk0?oc=5" target="_blank">Real-World Transition Strategies for Initiating Xanomeline–Trospium in Schizophrenia</a>  <font color="#6f6f6f">Psychiatrist.com</font>

Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia
Natureworld

Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE90X29BN0ZQSmxKN3NZcjVYU19KQk1zcEN4UURHTVBBRnVhQ3hvbjRBd1MtdHhGaUdHS1dvUTJsUXlnek9iWFcwOHJwcS10VDJRWDZrWHMxY2tDY2d3cmc0?oc=5" target="_blank">Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia</a>  <font color="#6f6f6f">Nature</font>

Deprescribing Antipsychotics Based on Real-World Evidence to Inform Clinical Practice: Safety Considerations in Managing Older Adults with Dementia
Frontiersworld

Deprescribing Antipsychotics Based on Real-World Evidence to Inform Clinical Practice: Safety Considerations in Managing Older Adults with Dementia

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxNT1JJTWo3c2QzNGVhXzRublhhTlpXT3pSNGg3WjZYdWZIdmlfR1p3Yl92dF9oSWxxTlVFX2lUcEhUX2hNWjJUZXpzTURvNkRBUkN1VksxNjF5UTlQRm9fNzJ6NGZkY3lYM2o3MFNHQTcxM2FqV1NERU8zMnNDc1c1aTlIeDJRUHJNcWJxZWV5V3FLS3c?oc=5" target="_blank">Deprescribing Antipsychotics Based on Real-World Evidence to Inform Clinical Practice: Safety Considerations in Managing Older Adults with Dementia</a>  <font color="#6f6f6f">Frontiers</font>

Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study
Naturemarkets

Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE94c0JZaVNEM0s5Z1VuUTFZVGZHZlJoLXdaSDQzdEU3NUlCbkhyR1hqS2J6eElXSkxMTTFxaGMtU25mMDlfbEh6SXdPQkdqNE1SZE9GZEhGY2dudi10RXRB?oc=5" target="_blank">Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study</a>  <font color="#6f6f6f">Nature</font>

Can the Initial Antipsychotic Influence Years of Weight Gain?
Psychiatric Timestech

Can the Initial Antipsychotic Influence Years of Weight Gain?

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNVF9oTkhiMUQ1eG1lMFJBdm5EVWNEWllybC1VSlRKOTgwX0dwU0JGaHB2Z3BsSEN5OF9QbXd1LXhreXBQTUt0cllNaV9rSFVYQUNNbl9kdXNlQmVNN0EtUmNRZkxrWHozRGV2XzlEektkY3NJbWdtdm5zeHNOVjVoMjJYSDg2aVJoeHpIc2JKckdzUDE4d0VCUkplOHhyQ1k?oc=5" target="_blank">Can the Initial Antipsychotic Influence Years of Weight Gain?</a>  <font color="#6f6f6f">Psychiatric Times</font>

Long-term outcomes of Aripiprazole long-acting injectable: a 10-year mirror image study of patient acceptability and treatment effectiveness
Naturegeneral

Long-term outcomes of Aripiprazole long-acting injectable: a 10-year mirror image study of patient acceptability and treatment effectiveness

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5yaFU2WW1ZajlWaTBGZXRtTEpCVmRMc0xxeXlsNUlHSjFvY0VwanVCRXNJRmtwcEN2aGZWR1FXTWZhMUdUMFJoWVdyZTJVTlBRRENicE9uWl9EVjdReFFB?oc=5" target="_blank">Long-term outcomes of Aripiprazole long-acting injectable: a 10-year mirror image study of patient acceptability and treatment effectiveness</a>  <font color="#6f6f6f">Nature</font>

Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study | Schizophrenia
Naturegeneral

Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study | Schizophrenia

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBfMnh5MmZQWDRBT0pTM2FBMHZFeUotUDVIZnU3R3dCT3BZcU5uU3RRZmlLcUJJbUpzeDN6c3JkeXEtOTdLZEYzNlJDNWsycVB2OTJSLUtycjIzRTV1YUdZ?oc=5" target="_blank">Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study | Schizophrenia</a>  <font color="#6f6f6f">Nature</font>

A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system
Frontiersworld

A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNZVJmajd4RVZEODdyX1ltQUgwQ0NCei1fRnJyQjduelZZQlEwMVlyRjl3NGprYmxfb3FBenJXVTU1TEF2eVVESjYxc1hDc0ZIX0ZuRHBxZzR0YnRaZHowb19sQWtMSFZrSUNzYzJRNjZRaWs0N1RLX2dXSWhvbDMxdGxaVmx2ZVVKanFKd1o4ZGZpb3F4?oc=5" target="_blank">A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system</a>  <font color="#6f6f6f">Frontiers</font>

Use of Long-Acting Injectable Antipsychotic Medications in Schizophrenia Treatment
Pharmacy Timesgeneral

Use of Long-Acting Injectable Antipsychotic Medications in Schizophrenia Treatment

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxPdFFFQzlSZHZkeHpnT2MzaTh0R1hiZV9EUE5MTVYyVElWZ1R5a3JwLTBpMks0d3l1a3ZRQmI5eHNjbFVnc1F4TGluakFaQVczWDd4TUJNZ1U5dnRpTkN0YnhvV01HSEZwOGhvdmc1aWRhbHRlaWNEUmdpM2JOV0FVOU5iT1M3UUhMSy11cm9rWGVFdHdINXo1enJ6cU5nYk9fak8wdUtzQ3VVSmFtZWE5cW9XbXFpazdr?oc=5" target="_blank">Use of Long-Acting Injectable Antipsychotic Medications in Schizophrenia Treatment</a>  <font color="#6f6f6f">Pharmacy Times</font>

Patterns of antipsychotic prescription in inpatient and outpatient psychiatric settings: a real world study
Cambridge University Press & Assessmentworld

Patterns of antipsychotic prescription in inpatient and outpatient psychiatric settings: a real world study

<a href="https://news.google.com/rss/articles/CBMisAJBVV95cUxNejJzX3JZV1dyVG5EM0VmM2pfemRmdFZrUXFTb0ZPQlpyek5IdnM4aEhob1dCbHJ6S0drUFZtdXZCMzN5SkdkQm5HLXd2bzV2Zlp1dW4wd1NicnNqMWFQNjRTSEM0RjFmN0RBZjIyMkNPd2xaazlaeU5VX09jakVtcE82Qno5VXp0VUxZeDN3OGdCcHpHOF9DQ1NFMmhmZEFwdDZJNlVkdnFvYlhMVjJKZ2diVmxBRG1RUUtqRTJyRlhkTFI5S1NQcVh1bnU3SWpsQ2JTNFpudkdJVERKQTNUSllMdGRLYXhoZk9sUEF0cmNqVEFiY0RGZnhVYmhJeGRwM2syTXA3Y0haaDlwQVMwSlJVZVJ2dC1vU0Q4VkNSbjdKNlFHMEVCMG11cXZTazQt?oc=5" target="_blank">Patterns of antipsychotic prescription in inpatient and outpatient psychiatric settings: a real world study</a>  <font color="#6f6f6f">Cambridge University Press & Assessment</font>

How can we improve the care of patients with schizophrenia in the real-world? A population-based cohort study of 456,003 patients | Molecular Psychiatry
Natureworld

How can we improve the care of patients with schizophrenia in the real-world? A population-based cohort study of 456,003 patients | Molecular Psychiatry

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9kSVYxZlJXdUlyZzkwajBRa3JyNHJqM0dDeWktMzZGV3JHdU9KejBzVlRvQUotMmNpQ0hJTGxxQmpHM2VZY25vT2NYUXJYcmhhSDdqamxVWWlZdk5BSmlZ?oc=5" target="_blank">How can we improve the care of patients with schizophrenia in the real-world? A population-based cohort study of 456,003 patients | Molecular Psychiatry</a>  <font color="#6f6f6f">Nature</font>

Evaluation of atypical antipsychotics associated rhabdomyolysis using the FDA adverse event reporting system database
Naturegeneral

Evaluation of atypical antipsychotics associated rhabdomyolysis using the FDA adverse event reporting system database

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5SbHhZZGEyMWNQNU9Fem5nMW9LdnBZSkhzVnhhTjVjX25fUUVxNS1rY2VZYVF0SXB3ckE1bDktaHhZeWxiVEJvenE3MGlubndhajNybTduQWhQNEh0Nklj?oc=5" target="_blank">Evaluation of atypical antipsychotics associated rhabdomyolysis using the FDA adverse event reporting system database</a>  <font color="#6f6f6f">Nature</font>

Outcomes With Early Long-Acting Injectable Antipsychotic Use in Schizophrenia
Psychiatric Timesgeneral

Outcomes With Early Long-Acting Injectable Antipsychotic Use in Schizophrenia

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNRHZ5SFhRc2Joc0s3MzJGYXBGdjZ4UVBmX0hUdFF1YlozNW5IVF8zc2lZVHhzR1ZsclRoNmNuczFYTUtpWl9mYkVRVlY3OXptOUVNTFF6OTMzQjMtZ3p4RTRRS2lvc1dOcFpQQ2RHZVJ0M2xTeDNkWHI1QTZzeUNnZy1lNTdsY1ZXanZKR2lsR2hCMGJLWTVKY0xBc3hhVExkbS1rODFBNVVkV1IzTkVYc3BQWXhHUQ?oc=5" target="_blank">Outcomes With Early Long-Acting Injectable Antipsychotic Use in Schizophrenia</a>  <font color="#6f6f6f">Psychiatric Times</font>

Mechanism and Trial Data for an Antipsychotic Agitation Therapy
NeurologyLivegeneral

Mechanism and Trial Data for an Antipsychotic Agitation Therapy

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxOeHh0QnFDbzBSVGdadDg1UVZvZlh1bzBkcUphY0pMNnlnMG1EYnpXVGluWTRoMXhuald1UW8wSE0xZEt1LXRTYjQ3YnFlQTNYRFdjTzdMbmREbDdpRGUzVFN4TVhYR1phOWgzcDRoX3h0cldQS1hnNTJnbVpOcU9SX0hlVktYM3VWNHhUZHY4akR0ck1iNVBOQzByMkYxZHM?oc=5" target="_blank">Mechanism and Trial Data for an Antipsychotic Agitation Therapy</a>  <font color="#6f6f6f">NeurologyLive</font>

Characteristics of Eye Disorders Induced by Atypical Antipsychotics
Physician's Weeklygeneral

Characteristics of Eye Disorders Induced by Atypical Antipsychotics

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQMkJUTDYwLU1hYkFONTg0RUVoZjdBb0d3d1dkdlpiakp0UVk0bDQzRTJ0SUJWTVREYlhMakZBRUotWTVVVEhJTW9xSVBQSkdMZ0JMMnc0aFNiRWJKb3NNRE9vX0ZKa0Q5UHk1MnlxVURvR3RDcVg4OEZlNDBUcUM0dnRORUd1eFlLcldsNV9FRl8wcmZad21Gdg?oc=5" target="_blank">Characteristics of Eye Disorders Induced by Atypical Antipsychotics</a>  <font color="#6f6f6f">Physician's Weekly</font>

Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects
Frontierstech

Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxNQkMxTXo0TzBudlVMN0xFN1RIa0RZVV81WUhXeG9POXFyWk4zTER0bGlsYmFtNmhQcXlPLWdza2oyQXF4R1BBd2J1QjFuMXZTVVcyTjdCLVNFTk43blI4OS00d0V0VG1WZm5DZXFIZzE5ajFDVTNMWWlDTWtvZ1MzRTl6YlNITGdhNUVSbXlEUWdybVE?oc=5" target="_blank">Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects</a>  <font color="#6f6f6f">Frontiers</font>

Real-World Data Link LAI Risperidone to Fewer Emergency Visits in Schizophrenia, Improved Bipolar Treatment
Psychiatric Timestech

Real-World Data Link LAI Risperidone to Fewer Emergency Visits in Schizophrenia, Improved Bipolar Treatment

<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxNQVpWcl9SYmlOMGVxSnM4ekZ4emJqV1MteHE4OWN3X3ppWXVVYVpCbkhUOUdHWGtjdW9zZUN0eVBnSzFTTmRKa2NRQ3lMTDRZY1psWE1lTWJ2ak5jdjJwd3hBeTVBbXZNZnAtMUtveEIydVJ1eWRhZ2VseDktdExJb2NoQ21mZi1RUUtESUpDZ056c1NoYTVZcEtkMVZ5aU9mZnRCQU5QeFFtaHRoLWtQWUVrU3VLOGlUYmdYVVRNVWlhbU83UndBYVdxU1hVR3doQTVFNUprZEVXemRO?oc=5" target="_blank">Real-World Data Link LAI Risperidone to Fewer Emergency Visits in Schizophrenia, Improved Bipolar Treatment</a>  <font color="#6f6f6f">Psychiatric Times</font>

New Insights Into Xanomeline/Trospium
Psychiatrist.comgeneral

New Insights Into Xanomeline/Trospium

<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTE5idENpbm94QjRYTU1fRnJyMFU1NHZ1S3J3Rm5sMXJ5bHpKN1kybFVJNWZvNmU4Z1JxSmFIMWd3NDdFOG9KdklDVGtZalkxNF9WdUJQdWpVNWVVY0FZd0lPOVBUYWtVMzB1T0VablF2czFqb0JpSHBBMXA3azE?oc=5" target="_blank">New Insights Into Xanomeline/Trospium</a>  <font color="#6f6f6f">Psychiatrist.com</font>

"Real-world antipsychotic" — Live Google News Trends & Headlines